Newsroom
Gilead has yet to set a price for the coronavirus treatment remdesivir, but an influential drug pricing watchdog says it could be worth up to $4,500 per patient
Business Insider
05.04.2020
Podcast: ‘An Arm And A Leg’: If Insurer Bills You For COVID Testing, Talk — And Maybe Tweet — It Out
Kaiser Health News
04.30.2020
As frontline emergency doctors risk all to fight COVID-19, their pay is slashed
Houston Chronicle
04.24.2020
How Much More Than Medicare Do Private Insurers Pay? A Review of the Literature
Kaiser Family Foundation
04.20.2020
Medical Staffing Companies Cut Doctors’ Pay While Spending Millions on Political Ads
ProPublica
04.20.2020
One in 12 ambulatory surgery center visits may result in a surprise bill
Modern Healthcare
04.20.2020
The COVID-19 Pandemic: Practice And Policy Considerations For Patients With Opioid Use Disorder
Health Affairs
04.06.2020
Alternative Drug Purchasing Arrangements Do Not Justify Raising The Prices Medicaid Pays For Brand Drugs
Health Affairs
04.03.2020
Alternative Drug Purchasing Arrangements Do Not Justify Raising The Prices Medicaid Pays For Brand Drugs
Health Affairs
04.03.2020
KFF Health Tracking Poll: The Impact Of Coronavirus On Life In America
Kaiser Family Foundation
04.02.2020
‘You’ve been served’: Wisconsin hospitals sue patients over debt — even during pandemic
Wisconsin Watch
04.02.2020
Coronavirus highlights black Americans must be protected from surprise medical billing
The Hill
04.02.2020
